SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
ImmunityBio converts from Immunomedics
An SI Board Since February 2023
Posts SubjectMarks Bans Symbol
1504 51 0 IBRX
Emcee:  TinfoilHat Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
785Exactly what the shorts want you to think. but they will probably stop selling nbobbseytwins2001312/31/2024
784A nice fresh 52 week low.... pretty disgusting if you ask me... Tax loss sellJJINV-12/31/2024
783BioSpace news Dec 23, 2024. 5 Companies that celebrated first approvals in 2024Redman1234112/30/2024
782biospace.comRedman1234-12/30/2024
781I missed this article. Sorry if it's a repost. observertoday.commannamal-12/28/2024
780Hey all, sorry have been traveling and family time, work life is busy and haven&TinfoilHat412/27/2024
779FDA Clinical Trial website was updated 12/20/24 and showed both NSCLC P3 EstimatRedman1234-12/27/2024
778events.jspargo.com Immunitybio booth at the 2025 Genitourinary Cancers Symposiumannamal-12/26/2024
777The estimated Study Completion is 2029-01, and the Primary Completion is 2028-09Redman1234-12/26/2024
776Clinicaltrials.gov says: " This is a randomized, open-label, phase 3 cliniEnd2War-12/26/2024
775stkt.coRedman1234-12/25/2024
774Please someone correct me if I’m mistaken, but the NSCLC P3 trial is slated to sRedman1234-12/25/2024
773OK we now know Serum Institute of India has applied for the filing of Anktiva inRedman1234512/24/2024
772Hardly surprising, but this hit the wire this morning: BENZINGA Dec-20-2024 10luckydog88112/20/2024
771As others have mentioned, if only we didn't have a CEO/majority owner who seluckydog88312/17/2024
770AI comments on Anktiva as backbone for Keytruda Tuesday, December 17, 202End2War612/17/2024
769The key is the extra shares post conversion of the new $505M at the lower converwaitwatchwander112/17/2024
768Yes, I am still trying to work out how many shares IBRX will have outstanding whjargonweary-12/17/2024
767In my prior post, I interpreted the Prospectus supplement to mean that $5.427/shEnd2War-12/17/2024
766for what it is worth ....... my loaned IBRX shares were all returned to me todaluckydog88312/16/2024
765PROSPECTUS SUPPLEMENT (To Prospectus dated April 17, 2024) 33,333,334 SharesEnd2War-12/16/2024
764deletedEnd2War-12/16/2024
763So after reading through the SEC filings; the recent stock offering (below markeDavidoff-12/16/2024
762That and penny stocks (under $5) are unavailable to short at most traditional brRedman1234-12/15/2024
761I’m curious what if any the new SEC rule on Short Selling taken effect on Jan 2,Redman1234-12/15/2024
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News